Heribert Jürgens

18.4k total citations · 4 hit papers
186 papers, 11.9k citations indexed

About

Heribert Jürgens is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Heribert Jürgens has authored 186 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pulmonary and Respiratory Medicine, 33 papers in Surgery and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Heribert Jürgens's work include Sarcoma Diagnosis and Treatment (94 papers), Bone Tumor Diagnosis and Treatments (30 papers) and Cardiac tumors and thrombi (26 papers). Heribert Jürgens is often cited by papers focused on Sarcoma Diagnosis and Treatment (94 papers), Bone Tumor Diagnosis and Treatments (30 papers) and Cardiac tumors and thrombi (26 papers). Heribert Jürgens collaborates with scholars based in Germany, Austria and United States. Heribert Jürgens's co-authors include Stefan Bielack, Michael Paulussen, R. Kotz, Winfried Winkelmann, A. Zoubek, Helmut Gadner, Silke Flege, Beate Kempf‐Bielack, M. Salzer‐Kuntschik and G. Ulrich Exner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Heribert Jürgens

181 papers receiving 11.7k citations

Hit Papers

Prognostic Factors in High-Grade Osteosarcoma of the Extr... 2000 2026 2008 2017 2002 2000 2003 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
    2002 1.4k citations Stefan Bielack, Beate Kempf‐Bielack et al. Journal of Clinical Oncology profile →
  2. Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group
    2000 744 citations Simon Cotterill, S. Ahrens et al. Journal of Clinical Oncology profile →
  3. Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
    2003 649 citations A. Zoubek, Ulrike Pötschger et al. Journal of Clinical Oncology profile →
  4. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2010 574 citations Pancras C.W. Hogendoorn, Nick Athanasou et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heribert Jürgens Germany 48 7.5k 3.2k 3.0k 2.3k 2.3k 186 11.9k
Stefano Ferrari Italy 56 7.3k 1.0× 2.8k 0.9× 3.5k 1.2× 2.0k 0.8× 2.0k 0.9× 206 10.0k
Alberto S. Pappo United States 60 6.7k 0.9× 4.2k 1.3× 2.0k 0.7× 2.4k 1.1× 2.4k 1.0× 308 11.6k
Peter Reichardt Germany 61 9.7k 1.3× 4.2k 1.3× 2.1k 0.7× 1.5k 0.7× 4.2k 1.9× 354 15.6k
Stefan Bielack Germany 52 8.6k 1.2× 3.8k 1.2× 3.8k 1.3× 4.1k 1.8× 2.3k 1.0× 215 14.0k
Gaetano Bacci Italy 51 6.3k 0.8× 2.4k 0.7× 3.1k 1.0× 1.7k 0.7× 2.0k 0.9× 123 8.7k
Brian P. Rubin United States 67 11.1k 1.5× 4.2k 1.3× 3.7k 1.2× 3.6k 1.6× 5.2k 2.3× 275 19.2k
Suzanne George United States 55 6.8k 0.9× 3.7k 1.1× 863 0.3× 1.8k 0.8× 2.1k 0.9× 257 11.7k
Douglas S. Hawkins United States 51 5.9k 0.8× 2.4k 0.7× 1.7k 0.6× 1.8k 0.8× 1.7k 0.7× 252 8.7k
G. Petur Nielsen United States 59 5.1k 0.7× 2.8k 0.9× 4.2k 1.4× 1.9k 0.8× 2.1k 0.9× 221 10.3k
Michael P. LaQuaglia United States 61 5.4k 0.7× 3.4k 1.1× 1.7k 0.6× 3.6k 1.6× 3.4k 1.5× 325 13.3k

Countries citing papers authored by Heribert Jürgens

Since Specialization
Citations

This map shows the geographic impact of Heribert Jürgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Jürgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Jürgens more than expected).

Fields of papers citing papers by Heribert Jürgens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heribert Jürgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Jürgens. The network helps show where Heribert Jürgens may publish in the future.

Co-authorship network of co-authors of Heribert Jürgens

This figure shows the co-authorship network connecting the top 25 collaborators of Heribert Jürgens. A scholar is included among the top collaborators of Heribert Jürgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heribert Jürgens. Heribert Jürgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Störk, Theresa, Andreas Ranft, Clemens Aigner, et al.. (2025). Primary Mediastinal Ewing’s Sarcoma: Post Hoc Analysis from Two International Multicenter Prospective Randomized Trials. Cancers. 17(1). 118–118.
2.
Bielack, Stefan, Beate Kempf‐Bielack, G. Delling, et al.. (2023). Prognostic Factors in High-Grade Osteosarcoma of theExtremities or Trunk: An Analysis of 1,702 Patients Treatedon Neoadjuvant Cooperative Osteosarcoma Study GroupProtocols. Journal of Clinical Oncology. 41(27). 4323–4337. 24 indexed citations
3.
Zöllner, Stefan, et al.. (2021). Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma. Cancers. 13(9). 1990–1990. 7 indexed citations
4.
Paulides, Marios, Wolfgang Stöhr, Hans‐Jürgen Laws, et al.. (2011). Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: A report from the Late Effects Surveillance System. Vaccine. 29(8). 1565–1568. 8 indexed citations
5.
Thomas, David M., Miriam Wilhelm, Anne‐Marie Cleton-Jansen, et al.. (2011). Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology. Journal of Adolescent and Young Adult Oncology. 1(3). 118–123. 1 indexed citations
6.
Frühwald, Michael C., et al.. (2011). Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatric Blood & Cancer. 59(4). 621–626. 20 indexed citations
7.
Deley, Marie‐Cécile Le, Olivier Delattre, Karl‐Ludwig Schaefer, et al.. (2010). Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial. Journal of Clinical Oncology. 28(12). 1982–1988. 125 indexed citations
8.
Ladenstein, Ruth, Ulrike Pötschger, Marie‐Cécile Le Deley, et al.. (2010). Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial. Journal of Clinical Oncology. 28(20). 3284–3291. 350 indexed citations
9.
Hogendoorn, Pancras C.W., Nick Athanasou, Enrique de Álava, et al.. (2010). Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v204–v213. 574 indexed citations breakdown →
10.
Potratz, Jenny, Darren N. Saunders, Daniel Wai, et al.. (2010). Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas. Cancer Research. 70(21). 8770–8781. 55 indexed citations
11.
Bielack, Stefan, Beate Kempf‐Bielack, D. Branscheid, et al.. (2008). Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients. Journal of Clinical Oncology. 27(4). 557–565. 167 indexed citations
12.
13.
Rübe, Claudia E., Claudia E. Rübe, F. van Valen, et al.. (2003). Ewing’s sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-α (tnf-α) after radiation exposure. International Journal of Radiation Oncology*Biology*Physics. 56(5). 1414–1425. 20 indexed citations
14.
Rödl, Robert, Christiane Hoffmann, Georg Gosheger, et al.. (2003). Ewing's sarcoma of the pelvis: Combined surgery and radiotherapy treatment. Journal of Surgical Oncology. 83(3). 154–160. 51 indexed citations
15.
Ferrari, Stefano, Mario Mercuri, Gaetano Bacci, Stefan Bielack, & Heribert Jürgens. (2002). Comment on "prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols" [5] (multiple letters). Journal of Clinical Oncology. 20(12). 2910–2911. 11 indexed citations
16.
Schuck, Andreas, Christian Rübe, Stefan Könemann, et al.. (2002). Postoperative Radiotherapy in the Treatment of Ewing Tumors: Influence of the Interval between Surgery and Radiotherapy. Strahlentherapie und Onkologie. 178(1). 25–31. 22 indexed citations
17.
Graf, Norbert, et al.. (2002). Telemedizin in der Pädiatrischen Onkologie. Klinische Pädiatrie. 28(1). 8–19. 3 indexed citations
18.
Cotterill, Simon, S. Ahrens, Michael Paulussen, et al.. (2000). Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group. Journal of Clinical Oncology. 18(17). 3108–3114. 744 indexed citations breakdown →
19.
Calaminus, Gabriele, et al.. (1989). Erfahrungen mit der Kombination Carboplatin/VP16 in der Behandlung rezidivierter Tumoren im Kindesalter. Klinische Pädiatrie. 201(4). 311–315. 1 indexed citations
20.
Winkler, K., G. Beron, Heribert Jürgens, et al.. (1983). Therapie der akuten Lymphoblastenleukämie im Kindesalter Multizentrische prospektive Therapiestudie COALL-80. Oncology Research and Treatment. 6(1). 26–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Ferrari Breakdown of academic impact, for papers by Alberto S. Pappo Breakdown of academic impact, for papers by Peter Reichardt Breakdown of academic impact, for papers by Stefan Bielack Breakdown of academic impact, for papers by Gaetano Bacci Breakdown of academic impact, for papers by Brian P. Rubin Breakdown of academic impact, for papers by Suzanne George Breakdown of academic impact, for papers by Douglas S. Hawkins Breakdown of academic impact, for papers by G. Petur Nielsen Breakdown of academic impact, for papers by Michael P. LaQuaglia
Rankless by CCL
2026